Product
Sa-5Ag
Aliases
Sa-5Ag full dose adjuvanted, Sa-5Ag full dose non-adjuvanted, Sa-5Ag half dose adjuvanted, Sa-5Ag half dose non-adjuvanted
1 clinical trial
2 indications
Indication
InfectionsIndication
Soft TissueClinical trial
A Phase I/II, Observer-blind, Randomised, Placebo-controlled Study to Assess Safety, Immunogenicity and Efficacy of GSK S. Aureus Candidate Vaccine When Administered to Healthy Adults (Dose-escalation) and to Adults 18 to 64 Years of Age With a Recent S. Aureus Skin and Soft Tissue Infection (SSTI)Status: Active (not recruiting), Estimated PCD: 2024-03-14